293. Deputy Ken O'Flynn asked the Minister for Health whether continued funding of non-statutory bodies is explicitly linked to demonstrated performance against agreed objectives; and if so, the mechanisms used to assess performance and determine funding continuation or adjustment. [27830/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn .
3,835 questions match, newest first.
360. Deputy Ken O'Flynn asked the Minister for Health whether her Department has established a formal, national definition of “clinically critical medicines”; and if so, the criteria used to determine such classification; and if she will provide the current list of medicines designated under this definition. [27514/26]
361. Deputy Ken O'Flynn asked the Minister for Health whether a formal risk-assessment or stratification model is in place to categorise medicines by clinical criticality and patient safety risk; and the methodology used within such a model; and if she will outline how it is applied in practice across the health service. [27515/26]
362. Deputy Ken O'Flynn asked the Minister for Health whether respiratory emergency medicines, including salbutamol nebules, are classified as clinically critical within any national prioritisation system; and if she will detail the specific safeguards applied to ensure continuity of supply for such medicines. [27516/26]
363. Deputy Ken O'Flynn asked the Minister for Health the governance structure underpinning the Medicines Criticality Assessment Group; the decision-making authority within that structure; and the level at which final determinations are made in relation to supply risk mitigation actions. [27517/26]
364. Deputy Ken O'Flynn asked the Minister for Health whether formal escalation thresholds exist within the medicines shortages framework based on clinical risk levels; and if so, the criteria for escalation; and the actions triggered at each level. [27518/26]
365. Deputy Ken O'Flynn asked the Minister for Health whether minimum stockholding requirements or buffer stock policies are in place for medicines deemed clinically critical; and the basis on which such levels are determined; and the mechanisms used to monitor compliance. [27519/26]
366. Deputy Ken O'Flynn asked the Minister for Health whether national early warning or predictive monitoring systems are in place to identify potential shortages of clinically critical medicines in advance; and if she will outline the data sources and indicators used within such systems. [27520/26]
367. Deputy Ken O'Flynn asked the Minister for Health the number of recorded patient safety incidents, adverse clinical outcomes, or treatment disruptions linked to medicine shortages in each of the past five years; and whether such data is centrally collected and analysed. [27521/26]
368. Deputy Ken O'Flynn asked the Minister for Health which body holds ultimate accountability for ensuring continuity of supply of clinically critical medicines at national level; and the oversight mechanisms in place to monitor performance against this responsibility. [27522/26]
369. Deputy Ken O'Flynn asked the Minister for Health the preparatory steps that have been taken to align national policy with the forthcoming European Union list of critical medicines; and whether an interim national list is in operation pending the introduction of EU measures. [27523/26]
2630. Deputy Ken O'Flynn asked the Minister for Health further to confirmation from Children’s Health Ireland that it does not provide gender-related assessment or treatment for minors, to set out the current national policy governing the assessment, referral, and treatment pathways for minors presenting with gender-related distress; and to specify the bodies responsible for each stage of that pathway. [23648/26]
2631. Deputy Ken O'Flynn asked the Minister for Health to detail the clinical governance framework applicable to any gender-related assessment, referral, or treatment of minors within the State, including the oversight role of the Department, the HSE, and any other relevant bodies. [23649/26]
2632. Deputy Ken O'Flynn asked the Minister for Health to specify the evidence-based clinical guidelines, protocols, or international standards currently adopted or recognised by the State in respect of gender-related assessment or treatment pathways for minors. [23650/26]
2633. Deputy Ken O'Flynn asked the Minister for Health to outline the audit, monitoring, and review mechanisms in place to ensure compliance with clinical governance, safeguarding, and evidence-based practice in respect of gender-related assessment and treatment pathways for minors. [23651/26]
2634. Deputy Ken O'Flynn asked the Minister for Health to confirm whether a single national service, lead clinician, or designated authority has responsibility for coordinating gender-related assessment and treatment pathways for minors; and if not, to set out how responsibility is currently distributed. [23652/26]
2635. Deputy Ken O'Flynn asked the Minister for Health to provide the total number of minors referred for gender-related assessment in each of the past five years, and to indicate the services or pathways to which such referrals were directed. [23653/26]
2636. Deputy Ken O'Flynn asked the Minister for Health to confirm whether any independent review, audit, or evaluation has been conducted since 2020 into the governance, clinical standards, or outcomes associated with gender-related assessment or treatment pathways for minors; and to provide details of same. [23654/26]
2638. Deputy Ken O'Flynn asked the Minister for Health to set out for each of the past five years, the total number of complaints made by employees within the Health Service Executive relating to sexual assault, sexual misconduct and workplace violence perpetrated by colleagues; the number of such complaints that were resolved informally, subject to formal investigation and upheld following investigation; whether all…
2642. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive maintains a monthly record of funded but unfilled posts at Cork University Hospital; if so, the number of such posts for each month in 2024, and the total associated salary allocation in each month, in tabular form; and if such records are not maintained, to outline the governance, reporting and oversight arrangements in place…
2646. Deputy Ken O'Flynn asked the Minister for Health to specify the clinical and operational risk thresholds that must be satisfied before patient transfer to the National Children's Hospital can proceed, particularly during the November to March period [23677/26]
2647. Deputy Ken O'Flynn asked the Minister for Health whether a formal written risk assessment on winter patient transfer has been completed; if so, to provide the date of completion and whether it will be published [23678/26]
2648. Deputy Ken O'Flynn asked the Minister for Health the contingency protocols in place in the event that transfer coincides with peak winter pressures, including escalation triggers and deferral mechanisms. [23679/26]
2649. Deputy Ken O'Flynn asked the Minister for Health to identify the individual or body with final decision-making authority regarding the timing of patient transfer to the National Children's Hospital. [23680/26]
2650. Deputy Ken O'Flynn asked the Minister for Health whether any independent external clinical or operational review has been commissioned in respect of the transfer plan; and if so, to provide details. [23681/26]